Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Troy Lister currently holds 32,000 shares of Verve Therapeutics, Inc. (VERV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Troy Lister has been a net neutral trader of VERV stock. They have purchased $0 and sold $0 worth of shares.
Troy Lister's most recent insider trade was on Jul 25, 2025, when they sold 6,952 shares at $0.00 per share.
Troy Lister serves as Executive at Verve Therapeutics, Inc. (VERV). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Troy Lister holds the position of Executive at Verve Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Troy Lister has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Troy Lister was on Jul 25, 2025, when they sold $0 worth of VERV shares. This transaction involved 6,952 shares at N/A per share.
Troy Lister currently owns 32,000 shares of Verve Therapeutics, Inc. (VERV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Troy Lister's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Troy Lister has 2 Form 4 filings on record as an insider at Verve Therapeutics, Inc..
Set alerts for Troy Lister and 40,000+ other insiders.